Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of (225)Ac-PSMA (Prostate-Specific Membrane Antigen)

Radioligand therapy is a type of internal radiotherapy combining a short-range radioisotope labeled to a carrier with a high affinity for a specific receptor expressed on tumor cells. Targeted alpha therapy (TAT) combines a high-linear energy transfer (LET) emitter ((225)Ac) with a prostate-specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Belli, Maria Luisa, Sarnelli, Anna, Mezzenga, Emilio, Cesarini, Francesco, Caroli, Paola, Di Iorio, Valentina, Strigari, Lidia, Cremonesi, Marta, Romeo, Antonino, Nicolini, Silvia, Matteucci, Federica, Severi, Stefano, Paganelli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674768/
https://www.ncbi.nlm.nih.gov/pubmed/33251129
http://dx.doi.org/10.3389/fonc.2020.531660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674768/
https://www.ncbi.nlm.nih.gov/pubmed/33251129
http://dx.doi.org/10.3389/fonc.2020.531660

Ejemplares similares